What are the recent financial highlights of POLY MEDICURE LIMITED?

POLY MEDICURE LIMITED recently reported a total revenue of ₹1,607.08 Cr and a net profit margin of 19.61%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of POLY MEDICURE LIMITED?

POLY MEDICURE LIMITED offers a dividend yield of 0.15%, with a dividend rate of ₹3.0 per share.

What are the key financial metrics of POLY MEDICURE LIMITED?

Key financial metrics include a trailing P/E ratio of 60.899223, forward P/E of 255.72917, book value of ₹266.964, price-to-book ratio of 7.3567977, and a market capitalization of ₹199.00 billion.

What does POLY MEDICURE LIMITED do?

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Polymed

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Polymed

Latest updates related to Polymed

Sr No.	Title	Sentiment
1	Declining Stock and Decent Financials: Is The Market Wrong About Poly Medicure Limited (NSE:POLYMED)? Simply Wall St	🔄
2	Polymed lines up ₹750 crore for expansion, buys over two years The Economic Times	🔄
3	Photys licenses rights to Polymed’s IRAK-4 degrader BioWorld Online	🔄
4	Photys Therapeutics Enters into Exclusive License Agreement with Polymed for Phase 1-Ready IRAK4 Degrader, Furthering its Proximity-based Pipeline and Mission The Manila Times	🔄
5	Poly Medicure Limited (NSE:POLYMED) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St	🔄
6	Indian company Polymed is localizing the production of hemodialysis products in Russia GxP News	🔄
7	Hangzhou Polymed Biopharmaceuticals divulges new inhibitors of FLT3 and IRAK-4 BioWorld Online	🔄
8	Some Shareholders Feeling Restless Over Poly Medicure Limited's (NSE:POLYMED) P/E Ratio Simply Wall St	🔄
9	Poly Medicure's (NSE:POLYMED) Returns On Capital Not Reflecting Well On The Business Simply Wall St	🔄
10	Poly Medicure Limited (NSE:POLYMED) insiders, who hold 42% of the firm would be disappointed by the recent pullback Simply Wall St	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

FIVESTAR DPWIRES ACCORD KRISHCA ALKALI QFIL ORIENTLTD SCILAL SMSPHARMA SHREDIGCEM